Vitamin B2 (Riboflavin)

The biosynthesis pathway of vitamin B2 or riboflavin is a metabolic process by which certain bacteria in the gut microbiome naturally produce riboflavin directly in your gut. Certain bacteria act as small factories for this vitamin, providing your intestinal cells with a local energy source that is crucial for fighting inflammation and keeping your mucosal barrier strong and protected.

Vitamin B2 is primarily obtained from foods such as dairy products, eggs, or leafy green vegetables, and is mainly absorbed in the first phase of digestion (in the small intestine). However, the cells lining your large intestine (colon) need their own constant supply of this vitamin to function correctly and survive daily stress. This is where your microbial ecosystem plays a fundamental role.

Riboflavin is a water-soluble vitamin that is a precursor to the cofactors FAD and FMN, essential molecules for redox reactions, cellular metabolism, and energy production. In the intestinal ecosystem, the ability to synthesize vitamin B2 de novo is widely distributed, with Bacteroidetes, Fusobacteria, and Proteobacteria being important producing phyla.

The ability of the gut microbiota to produce vitamin B2 has a direct impact on colon homeostasis and general health. Firstly, bacterial riboflavin is fundamental for maintaining the integrity of the intestinal barrier and mucosal health.

Furthermore, locally produced vitamin B2 possesses anti-inflammatory and antioxidant properties. Optimal levels of this synthesis pathway help regulate the immune response in the gastrointestinal tract, favoring an anti-inflammatory environment. Local vitamin B2 deficiency can compromise the barrier function of the mucosa, alter the energy metabolism of colonocytes, and is correlated with increased susceptibility to multisystemic imbalances.

Vitamin B2 Biosynthesis Capacity is quantified by analyzing the microbiome's genetic potential to complete the riboflavin metabolic pathway (KEGG pathway M00125). The algorithm detects the presence of key genes such as ribA, ribB, ribD, and ribE. The main producers identified mostly belong to the phyla Bacteroidetes, Proteobacteria, and Fusobacteria. As with vitamin B1, most Firmicutes lack the complete machinery for de novo synthesis.

High capacity reflects a self-sufficient metabolic network that supports mucosal barrier health. However, low capacity alerts to an absolute dependence on dietary riboflavin to maintain colon health. The clinical strategy for low levels requires ensuring adequate intake of vitamin B2 through diet (offal, almonds, spinach) or supplementation, along with the use of prebiotics to promote the growth of the main producing phyla.